BioCryst Pharmaceuticals
BCRX
#4411
Rank
$2.37 B
Marketcap
$9.46
Share price
-0.58%
Change (1 day)
26.20%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of December 2025 : $0.51 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are $0.51 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31$0.51 B4.84%
2024-12-31$0.49 B-5.13%
2023-12-31$0.51 B-6.01%
2022-12-31$0.55 B-6.49%
2021-12-31$0.58 B75.72%
2020-12-31$0.33 B90.96%
2019-12-31$0.17 B19.37%
2018-12-31$0.14 B-17.62%
2017-12-31$0.17 B98.4%
2016-12-31$89.84 M-26.57%
2015-12-31$0.12 B-10.6%
2014-12-31$0.13 B180.1%
2013-12-31$48.86 M-14.93%
2012-12-31$57.43 M-30.13%
2011-12-31$82.2 M-24.89%
2010-12-31$0.10 B-23.03%
2009-12-31$0.14 B67.89%
2008-12-31$84.69 M-40.66%
2007-12-31$0.14 B108.39%
2006-12-31$68.48 M-31%
2005-12-31$99.24 M205.68%
2004-12-31$32.46 M7.88%
2003-12-31$30.09 M-27.13%
2002-12-31$41.3 M-30.11%
2001-12-31$59.09 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
$59.02 B 11,379.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$82.30 B 15,908.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$3.34 B 551.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$2.94 B 473.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$1.17 B 128.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.58 B 13.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$8.35 M-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
$28.15 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$1.46 B 184.15%๐Ÿ‡บ๐Ÿ‡ธ USA